Medtronic stock forecast analysts tracking Medtronic stock

Analysts tracking Medtronic stock forecast highlight a 4% year-to-date gain, supported by stronger-than-expected Q3 device shipments. Revenue projections in the $8.1–$8.3 billion range give bullish traders confidence for Q1 2025 targets. Here's why I believe now is a good time to add shares of Medtronic to your portfolio. While Medtronic currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys. On-the-ground market data supports bullish medtronic stock forecast sentiment as global sales in emerging markets rise 8% year-over-year. Currency tailwinds may add another $0.05 to quarterly EPS.